Semaglutide is known to frequently cause gastrointestinal issues, including nausea, vomiting, and diarrhea, which can limit its tolerability for some patients
The following antibodies were used to stain the different cell populations: CD45 APC-Cy7 (clone 30-F11, BD Biosciences), CD11b PE-Cy7 (clone M1/70, BioLegend), CD31 Percp-Cy5.5 (clone 390, BioLegend), CD3 FITC (clone 145-2C11, BioLegend), and MHCII BV 421 (clone M5/114.15.2, BioLegend)
Each pen has four different doses which is a 30-day supply
Each injection delivers exactly the amount of semaglutide specified
But GLP-1s arent right for everyone
10.1111/j.1530-0277.1998.tb03666.x 93 GehlertD